Dozens of drug companies raised prices at a higher rate than inflation and will need to pay rebates to Medicare, the U.S. Department of Health and Human Services announced Thursday. The refunds are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback